Itamar Medical Stock Forecast, Price & News

Itamar Medical (NASDAQ:ITMR) Frequently Asked Questions

Is Itamar Medical a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Itamar Medical in the last year. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Itamar Medical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ITMR, but not buy additional shares or sell existing shares.
View analyst ratings for Itamar Medical or view top-rated stocks.

What stocks does MarketBeat like better than Itamar Medical?

Wall Street analysts have given Itamar Medical a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Itamar Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Itamar Medical?

Itamar Medical saw a decrease in short interest during the month of September. As of September 30th, there was short interest totaling 11,000 shares, a decrease of 92.4% from the September 15th total of 145,000 shares. Based on an average trading volume of 160,600 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.1% of the shares of the company are short sold.
View Itamar Medical's Short Interest.

When is Itamar Medical's next earnings date?

Itamar Medical is scheduled to release its next quarterly earnings announcement on Tuesday, November 16th 2021.
View our earnings forecast for Itamar Medical.

How were Itamar Medical's earnings last quarter?

Itamar Medical Ltd. (NASDAQ:ITMR) posted its quarterly earnings results on Tuesday, August, 31st. The company reported ($0.29) earnings per share for the quarter, missing analysts' consensus estimates of ($0.27) by $0.02.
View Itamar Medical's earnings history.

How has Itamar Medical's stock been impacted by Coronavirus (COVID-19)?

Itamar Medical's stock was trading at $11.11 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ITMR stock has increased by 173.1% and is now trading at $30.34.
View which stocks have been most impacted by COVID-19.

What guidance has Itamar Medical issued on next quarter's earnings?

Itamar Medical updated its FY 2021 earnings guidance on Tuesday, September, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $53 million-$54 million, compared to the consensus revenue estimate of $52.70 million.

What price target have analysts set for ITMR?

6 Wall Street analysts have issued 1 year price targets for Itamar Medical's shares. Their forecasts range from $30.00 to $33.85. On average, they expect Itamar Medical's stock price to reach $31.37 in the next year. This suggests a possible upside of 3.4% from the stock's current price.
View analysts' price targets for Itamar Medical or view top-rated stocks among Wall Street analysts.

Who are Itamar Medical's key executives?

Itamar Medical's management team includes the following people:

• Gilad Glick, President, CEO & VP-Sales & Marketing
• Shy Basson, Chief Financial Officer
• Efrat Litman, Vice President-Advanced Research & Development
• Jennifer Cook, Global Medical Director
• Eilon Livne, VP-Sales & Channels Development

Who are some of Itamar Medical's key competitors?

Some companies that are related to Itamar Medical include Codexis (CDXS), Cassava Sciences (SAVA), Global Blood Therapeutics (GBT), Myovant Sciences (MYOV), Quanterix (QTRX), Trillium Therapeutics (TRIL), Alector (ALEC), Establishment Labs (ESTA), Aurora Cannabis (ACB), Sema4 (SMFR), Rocket Pharmaceuticals (RCKT), Andlauer Healthcare Group (AND), IVERIC bio (ISEE), Allscripts Healthcare Solutions (MDRX) and Valneva (VALN).
View all of ITMR's competitors.

What other stocks do shareholders of Itamar Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Itamar Medical investors own include Gilead Sciences (GILD), AbbVie (ABBV), Carnival Co. & (CCL), Energy Transfer (ET), KeyCorp (KEY), Occidental Petroleum (OXY), Pfizer (PFE), (PRMW), Wells Fargo & Company (WFC) and Abbott Laboratories (ABT).

What is Itamar Medical's stock symbol?

Itamar Medical trades on the NASDAQ under the ticker symbol "ITMR."

How do I buy shares of Itamar Medical?

Shares of ITMR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Itamar Medical's stock price today?

One share of ITMR stock can currently be purchased for approximately $30.34.

How much money does Itamar Medical make?

Itamar Medical has a market capitalization of $488.72 million and generates $41.03 million in revenue each year.

How many employees does Itamar Medical have?

Itamar Medical employs 257 workers across the globe.

What is Itamar Medical's official website?

The official website for Itamar Medical is www.itamar-medical.com.

How can I contact Itamar Medical?

The company can be reached via phone at (724) 617-7000.